Any hopes of a last minute reprieve for countries facing tough US tariffs ended at midnight in Washington as Trump’s reciprocal levies kicked in, with the 104% on Chinese goods the highest.
Whether it’s viewed as rebalancing trading relationships to make it fairer for the US, or the highest tax rise on US citizens for decades, for global economies and American businesses the impact is real, and investors are taking it badly.
Tariffs are the driver of a 12% drop in the Dow Jones Industrial Average over four days, that’s 4,500 points lost, closing 0.9% lower Tuesday while the S&P 500 ended its session down 1.6% having been up 4% earlier in the day.
US futures indicate a flat start to the new day, but global equities are down with Europe off by around 3% and Asian markets mixed, with China notably higher despite the eyewatering tariffs amid fighting talk from Beijing, while also showing willingness to negotiate with the US.
But while the markets navigate the muddied waters of global trade, there may yet be further industry-specific tariffs to come.
President Trump said Tuesday that “We are going to be announcing very shortly a major tariff on pharmaceuticals.” The industry was one of those highlighted previously with the president annoyed that many US pharma firms have established themselves in the Republic of Ireland where corporate taxes are low.
While no details have been provided regarding potential rates of tariffs on pharmaceutical imports, those for auto, steel, and aluminium have been set at 25% which could be repeated for the drugmakers.
“Once we do that, they’re going to come rushing back into our country, because we’re the big market,” Trump told a Republican fundraiser. “The advantage we have over everybody is that we’re the big market.”
For now, markets will continue to react to what we know already, together with growing concerns about recession, inflation, the Fed, and when the bottom will be reached for US equity markets.
From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.
Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.
“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.
Sellers shift focus: It's not about succession anymore.
Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.
RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.
As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.
